Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized trial of paclitaxel hypersensitivity incidence with two steroid premedication regimens in gynecologic cancer
TCTR20151122001Completed
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of paclitaxel in gynecological cancer (2 arms), sponsored by none. Primary endpoint: Incidence of paclitaxel hypersensitivity reactions. Started Jun 2015; status: completed.
02
Drugs
paclitaxel
03
Conditions
gynecological cancer
Beyond the preview
Go deeper on TCTR20151122001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20151122001.